Phase 3 Trials Of Covaxin Begin In Bengaluru

On Day One, 50 people got the dose At least 50 people were given Covaxin, a covid-19 vaccine developed by Bharat Biotech on the first day of the initiation of phase three human clinical trials in Bengaluru. Bengaluru is one of 25 centres across 12 states in the country where clinical trials are being done. At least 26,000 trials are being conducted in these cent more

Watchlist